BOSTON, May 15, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jennifer Schneider, M.D., M.S., has been elected to its Board of Directors as an independent director.

In a recent transaction on August 8, Sangeeta N. Bhatia, a director at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), sold shares in the company, according to the latest SEC filings. The sale amounted ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of ...

Vertex Pharmaceuticals Inc. closed $45.72 below its 52-week high ($510.64), which the company achieved on August 1st.

According to Benzinga Pro, Vertex Pharmaceuticals's peer group average for short interest as a percentage of float is 6.15%, ...

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), ...

And we're really excited to have the Vertex IR team with us. We have Susie Lisa who is Senior Vice President, and Manisha Pai, who's Executive Director of IR ... our Q2 results were very strong across ...

The ACS Board of Directors, the Society's chief governing body ... Latimer is a Consultant in drug development with LHLatimer Consulting, formerly with Elan Pharmaceuticals. He earned his B.S. degree ...

Except for the last several days, the past 12 months have been pretty good for stocks across the board and especially successful for Vertex Pharmaceuticals (NASDAQ: VRTX). Shares of the biotech ...

Vertex Securities Ltd Director Discussions: Check out the latest updates, and news about the Vertex Secur. director discussions at India Infoline Investor Relations ESG Profile ...

Sept 17 (Reuters) - The independent directors of genetic testing firm 23andMe (ME.O), opens new tab said on Tuesday they have resigned from the company's board after not receiving a satisfactory ...

This was the stock's second consecutive day of losses.